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†Department of Physics and Astronomy and ‡Department of Bioengineering, Rice University, Houston, TexasABSTRACT Prestin is the membrane motor protein that drives outer hair cell (OHC) electromotility, a process that is essential
for mammalian hearing. Prestin function is sensitive to membrane cholesterol levels, and numerous studies have suggested
that prestin localizes in cholesterol-rich membrane microdomains. Previously, fluorescence recovery after photobleaching
experiments were performed in HEK cells expressing prestin-GFP after cholesterol manipulations, and revealed evidence of
transient confinement. To further characterize this apparent confined diffusion of prestin, we conjugated prestin to a photostable
fluorophore (tetramethylrhodamine) and performed single-molecule fluorescence microscopy. Using single-particle tracking, we
determined the microscopic diffusion coefficient from the full time course of the mean-squared deviation. Our results indicate
that prestin undergoes diffusion in confinement regions, and that depletion of membrane cholesterol increases confinement
size and decreases confinement strength. By interpreting the data in terms of a mathematical model of hop-diffusion, we quan-
tified these cholesterol-induced changes in membrane organization. A complementary analysis of the distribution of squared
displacements confirmed that cholesterol depletion reduces prestin confinement. These findings support the hypothesis that
prestin function is intimately linked to membrane organization, and further promote a regulatory role for cholesterol in OHC
and auditory function.INTRODUCTIONThe frequency selectivity, and sensitivity of mammalian
hearing is enhanced by fast electromechanical coupling of
transmembrane potential changes to rapid length changes
in cochlear outer hair cells (OHC) (1–3). This unique
form of cellular motion, termed electromotility, has a distinct
electrical signature that manifests as a robust nonlinear
capacitance (NLC) in the native OHC (4–6). The transmem-
brane protein prestin, expressed in the OHC lateral wall, has
been identified as the motor that drives electromotility (7).
Measurement of NLC as a test of prestin function has
become standard and is characterized experimentally by
measuring total charge movement and the voltage at peak
capacitance Vpkc: Mammalian cells, including HEK cells,
that exogenously express prestin gain NLC (8–11) and
have also been shown to exhibit voltage-induced motion
(7), validating their use as a model system in place of the
native OHC.
Prestin is predicted to have 10–12 membrane-spanning
helices (10), and numerous studies have demonstrated the
importance of understanding the interaction between prestin
and the cell membrane. Various manipulations of the plasma
membrane environment have been shown to affect prestin
function. For example, amphiphilic drugs that alter prestin
function also alter membrane curvature and mechanical
properties (12,13), and membrane substitution with lipids
of differing acyl-chain lengths shifts Vpkc due to changes
in membrane thickness (14). Prestin is generally considered
to undergo a voltage-dependent conformational change that
exerts force on the OHC lateral wall. Anisotropic lipid diffu-Submitted September 27, 2011, and accepted for publication July 25, 2012.
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the OHC cytoskeleton with the membrane (15). Thus,
manipulations that affect the organization and conforma-
tional flexibility of prestin could potentially affect prestin
and OHC function.
Membrane cholesterol, a well-characterized modifier of
prestin function, has received much attention because of
its potential physiological importance. OHC cholesterol
levels decrease during maturation of hearing in mice, and
manipulation of cholesterol levels in live adult mice affects
cochlear amplification (16). In both the OHC and HEK
cells, depletion of membrane cholesterol shifts Vpkc in the
depolarizing direction, and loading of membrane choles-
terol causes hyperpolarizing shifts (16–18). In addition,
depletion of membrane cholesterol enhances the mechanical
response of OHCs to electrical stimuli (19). Moreover,
confocal fluorescence images of prestin-transfected cells
show punctate foci in the membrane (16,17,20,21). Puncta
reversibly disappear upon cholesterol depletion and colocal-
ize with known lipid raft markers (16,17). The OHC lateral
wall, where prestin is functional, has lower membrane
cholesterol levels than the basal or apical regions (16),
where electromotility is not present (22). Biochemical
studies have shown the appearance of prestin in raft frac-
tions of membrane lysate (16,17) that decrease upon deple-
tion of membrane cholesterol. Taken together, these findings
suggest an important role for cholesterol and microdomains
in regulating prestin function, and motivate the measure-
ment of prestin diffusion to characterize possible interaction
of prestin with membrane compartments. Clearly, precise
knowledge about whether cholesterol alters the microscale
organization of prestin in the membrane is needed to inter-
pret existing data.http://dx.doi.org/10.1016/j.bpj.2012.07.052
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a powerful way to characterize the interactions of membrane
proteins with membrane substructures (23). Early indica-
tions that prestin is mobile came from indirect electrophys-
iological measurements (24,25). Later, direct measurements
of prestin diffusion employing fluorescence recovery after
photobleaching (FRAP) revealed that immobile fractions re-
mained after dual bleaches, suggesting that prestin is tran-
siently confined (20). However, because FRAP is an
ensemble measurement, a detailed analysis of the size and
character of the putative confinements was not possible,
and other, more-complex modes of diffusion could not be
ruled out (20). Thus, several questions remain to be
resolved. For example, does prestin diffuse within confine-
ment zones or can it become immobile due to binding
with structures in the membrane? Furthermore, does prestin
remain confined or can it diffuse or hop into other compart-
ments? Are these processes dependent on cholesterol?
To study prestin diffusion at a finer level of detail, one
must track single prestin molecules. Single-particle tracking
(SPT) is a powerful method that is commonly applied to
study the diffusion of membrane proteins and lipids at the
single-molecule level (26). In recent years, advances have
been made in analyzing and interpreting the motion of mole-
cules confined to membrane compartments (27–29). In
particular, the importance of the effects of detector aver-
aging and time resolution on confined diffusion (27,30)
have been characterized, and methods to correct for these
effects have been developed (28,29). In this study we use
SPT of prestin, conjugated to a minimally disruptive
fluorescent tag, to measure prestin lateral mobility and
investigate the effect of cholesterol on prestin diffusion.
We interpret our data using an analytical approximation to
hop-diffusion developed by Wieser et al. (28) and by
a complementary statistical analysis of the full distribution
of squared displacements (31). We find that prestin
undergoes confined diffusion in relatively large confine-
ments, and its diffusive behavior is significantly affected
by membrane cholesterol levels.MATERIALS AND METHODS
Details regarding the creation of a plasmid encoding for prestin-SNAP-tag,
cell culture, transfection, and labeling procedures are provided in the
Supporting Material. Also described in the Supporting Material are the
methods used to calculate prestin trajectories and the mean-squared devia-
tion (MSD), and to characterize the effects of detector averaging and local-
ization precision, which are needed for the detailed analysis of MSD and
step-size distributions described below.Cell treatments
To deplete membrane cholesterol, we used a protocol similar to that
described by Sfondouris et al. (18), which removes  60% of cholesterol
from the membrane fraction of HEK293 cells as determined using the
Bradford method and the Amplex Red Cholesterol Assay (Molecular
Probes, Eugene, OR). Transfected HEK293 cells were given a 20 min treat-Biophysical Journal 103(8) 1627–1636ment of 10 mM methyl-b-cyclodextrin (MbCD) in serum-free Dulbecco’s
modified Eagle’s medium at 37C and washed before imaging in HEPES
buffered saline. For control experiments, in which immobile prestin was
imaged, cells were fixed in 4% paraformaldehyde for 10 min before
imaging.Single-molecule microscopy
Complete details of our imaging protocol are provided in the Supporting
Material. Briefly, transfected cells are imaged using objective type total
internal reflection fluorescence (TIRF) microscopy. For each cell,
200-frame image stacks containing diffraction-limited signals in each frame
are collected (see Movie S1 and Movie S2). A characterization of non-
specific labeling is provided in the Supporting Material and Movie S3,
Movie S4, and Movie S5. The locations of the signals are determined in
each frame using software developed in-house with MATLAB (The
MathWorks, Natick, MA) and correlated between frames to construct 2D
trajectories. The MSD is calculated from an ensemble average of all the
trajectories as described in the Supporting Material.Analysis of MSD
To describe the measured MSD, we use the analytical hop-diffusion model
developed by Wieser et al. (28). This model extends the exact calculation
(32) of MSD for a particle totally confined to a corral of size L to an
array of partially permeable corrals using an analytical approximation.
Wieser et al. (28) included corrections for the effects of time averaging
(27,28,30,33) over the finite exposure time till. For the MSD, they find
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where Dmicro is the microscopic diffusion constant the particle would
have in the absence of confinement, and tlag is the time lag.
Dmacro ¼ ð1 aÞDmicro ¼ 1=bt Dmicro is the macroscopic diffusion constant
the particle appears to have over long observation times and describes the
hopping between corrals. a is the probability that the particle will remain
confined, which sets Dmacro; and is related to the confinement strengthbt ¼ Dmicro=Dmacro within the domains by bt ¼ 1=1 a (by definition,btR1 with bt/N=1 signifying totally impermeable/permeable barriers).
To fit the MSDðtlagÞ data with the hop-diffusion model, we truncated
the summation in Eq. 1 out to six terms to define our fitting
function MSDfitðtlagÞ. We found estimates of the three fitting parameters
(Dmicro; L, and a) by minimizing c
2 ¼Ptlag ½1=sMSDðtlagÞ ðMSDðtlagÞ
MSDfitðtlagÞÞ2; where weighting factor s2MSDðtlagÞ is the variance of MSD
at each tlag; using least-squares fitting (34) by the Levenberg-Marquardt
method in Origin (Northampton, MA). The error in each fit parameter is
the one-s confidence interval determined by finding the range in that
parameter, around the best fit, that produces Dc2 ¼ 1 while allowing the
other two parameters to vary. The confinement offset COcorr, corrected
for effects of detector averaging, is calculated from the fit parameters
a and L according to COcorr ¼ a2L2=3 (28). The error in COcorr using
Gaussian error propagation (34) is sCOcorr ¼ 2=3 aLðL2s2a þ a2s2LÞ1=2;
where sa and sL are the respective one-s errors in a and L. The error in
Cholesterol and Prestin Diffusion 1629the confinement strength bt is sbt ¼ ð1=1 aÞ2sa: The error in Dmacro is
sDmacro ¼ ðð1 aÞ2s2Dmicro þ D2micros2aÞ1=2:FIGURE 1 Sample trajectories of BG-TMR-labeled prestin-SNAP-tag
molecules in untreated HEK cells. Coordinate axes are the position
in mm. The frame time is 250.8 ms for all trajectories. Error bars in position
are fitting errors from Gaussian fits (Eq. S1) to spot intensity profiles. The
displayed sample trajectories were chosen for presentation based on longer-
than-average diffusion times before bleaching. Gray shapes outline plau-
sible apparent confinement regions. Discontinuities in some trajectoriesAnalysis of step-size distribution
The calculation of the squared step-size probability density distribution
pðDr2; tlagÞ was achieved by binning individually measured squared
displacements Dr2 at either tlag ¼ 250:8ms or 1:254s for all trajectories
combined, and normalizing the result to the total number of ob-
served step-displacements. The cumulative distribution function (CDF)
PðDr2; tlagÞ was calculated by cumulatively summing the pðDr2; tlagÞ
histogram (31):
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Experimentally measured CDF was fit to a function describing one diffu-
sive component,
P
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with two free parameters r2o and 3. The function FðDr2Þ represents the
CDF of apparent displacements measured for immobilized particles in fixed
cells (see Results and Fig. S3 in the Supporting Material), and 3is the frac-
tion of the diffusive component with characteristic squared diffusion length
r2o :Detector time averaging effects (33) and effects of positional uncertainty
(35) are taken into account for r2o by assuming r
2
oz4Dtlag þ D ð4=3ÞDtill:
See the Supporting Material and Fig. S1, Fig. S2, Fig. S3, and Fig. S5 for
a detailed analysis of detector averaging and positional accuracy effects.are due to cases in which the analysis software failed to detect the fluores-
cent signal in one or more frames. In these cases, it was visually clear that
the signal was the same as that in subsequent frames.RESULTS
SPT of prestin
We measured the trajectories of prestin-SNAP-tag labeled
with tetramethylrhodamine (TMR)-conjugated benzylgua-
nine (BG) substrate, which has the advantage of preventing
both cross-linking of prestin (due to one-to-one binding
stoichiometry of BG to SNAP-tag) and long observation
times (due to the photostability of TMR). Shown in Fig. 1
are sample prestin-SNAP-TMR trajectories in untreated
cells. The displayed trajectories are relatively long (ranging
from  8 48s or ~30–190 observed time steps) compared
with the average trajectory length of ~9s: The trajectories
display what appear to be subregions of confinement
varying in apparent size. The locations of the confinement
zones in some of the examples appear to hop in position,
and in others the trajectories appear to be confined to a single
localized region.
Because many tracks are too short to clearly observe the
confinement of motion in a single trajectory (36), we calcu-
lated the MSD of all recorded tracks for each of two groups
(control and cholesterol depleted) using Eq. S3. We first
analyzed prestin motion in untreated cells (Fig. 2, A (solid
circles) and B). As expected for confined diffusion, therise of MSDðtlagÞ clearly changes to a drastically shallower
slope as tlag increases. We also measured the MSD of prestin
in cells treated with 10 mM MbCD (Fig. 2, A and C, open
circles). In this case, we also observe a decrease in the slope
of MSDðtlagÞ at long tlag; however, the change in slope is less
obvious. To obtain quantitative estimates of quantities
related to confined diffusion, we performed fits (shown in
Fig. 2, A–C, red curves) of MSDðtlagÞ for untreated and
MbCD-treated groups to a hop-diffusion model using Eq.
1 (28). Due to the large variance in MSDðtlagÞ at long tlag;
we restricted our analysis to tlag%30s:
From the fit to the MSD of the control group, we conclude
that the average microscopic diffusion constant of prestin
within confinement zones in the HEK plasma membrane
is Dmicro ¼ 0:0481þ0:00290:0027mm2=s: We obtained fitted values
for L and a of 1:215þ0:0570:054mm and 0:908
þ0:018
0:016; respectively.
Using the fitted values and uncertainties of L and a, we
calculate the corrected confinement offset (i.e., the offset
that is produced only by diffusion within and hopping
between domains) to be COcorr ¼ 0:40650:041mm2:
Instead of quoting the fitted value of L as our estimate forBiophysical Journal 103(8) 1627–1636
FIGURE 2 MSD versus time for prestin-SNAP-TMR. (A) Measured
MSD against tlag in untreated (solid circles) and cholesterol-depleted
(open circles) cells. A total of 285 tracks were recorded for untreated cells
(nine cells), and 269 tracks were recorded for cells treated with 10 mM
MbCD (seven cells). Error bars are standard error of the mean. Increased
variance at long tlag result from decreased probability of observing long
trajectories due to photobleaching of TMR. Both data sets are fit to the
hop-diffusion model (Eq. 1, solid curve). Inset: Data are shown on a log
scale to emphasize fit to early points. The resulting fitting parameters are
(for untreated cells) a ¼ 0:908þ0:0180:016, L ¼ 1:215þ0:0570:054mm, and Dmicro ¼
0:0481þ0:00290:0027mm
2=s with c2n ¼ 0:6; and (for cells treated with MbCD)
a ¼ 0:659þ0:0390:039, L ¼ 2:15þ0:140:14mm, and Dmicro ¼ 0:0499þ0:00180:0018mm2=s with
c2n ¼ 0:67. Asymptotic behavior (black curves) of MSDhop for (B) untreated
and (C) MbCD-treated groups is shown superimposed on data and fit (red
curves). According to the hop-diffusion model, including averaging effects,
MSDhopðtlag/0Þ ¼ 4Dmicroðtlag  ð1=3ÞtillÞ and MSDhopðtlag/NÞ ¼
COþ 4Dmacrotlag, where CO ¼ ðL2a2=3Þð1þ ð4Dmicrotill=L2ÞÞ1  ð4=3Þ
ð1 aÞDmicrotill is a confinement offset seen as the y-intercept in B and C
(28). Macroscopic diffusion constants Dmacro : (B) 4:450:9 103mm2=s
and (C) 0:01750:002mm2=s.
FIGURE 3 CDF of squared step size at increased time lag. For both
groups, only displacements used to calculate MSDðtlag ¼ 1:254sÞ are
included. Bin size is dr2 ¼ 0:04mm2. CDF (solid circles) is fit to Eq. 3 (solid
curves). Also shown for comparison is a fit to a simple exponential
PðDr2; tlagÞ ¼ 1 expðDr2=r2oÞ (dashed curves). (A) A fit to the untreated
group using Eq. 3 gives r2o  D ¼ 0:250mm2 and 3¼ 0:575. (B) A fit to the
MbCD-treated group using Eq. 3 gives r2o  D ¼ 0:288mm2 and 3¼ 0:685.
Because the diffusive portion of the MbCD group fits perfectly with free
diffusion, it is appropriate to obtain the diffusion constant. We obtain
D ¼ 0:0615mm2=s. The variance of the fit to the MbCD-treated group
(S2 ¼ 2:67 103) is more than a factor of 10 smaller than the variance
of the fit to the untreated group (S2 ¼ 2:76 102).
1630 Kamar et al.the average domain size, we make a more conservative
estimate by calculating the full range in L implied by letting
a and the confinement offset COcorr vary by their maxi-
mum uncertainty ranges; this gives L in the interval
ð1:13; 1:30Þmm: The value obtained for a implies that the
confinement strength is bt ¼ 1152: This indicates strong
confinement, which is consistent with the nearly flat slope
of MSDðtlag/NÞ at large time lags (Fig. 2 B).
Results from fitting the MbCD-treated group indicate
that, within the fitting error, the microscopic diffusion
constant ðDmicro ¼ 0:049950:0018mm2=sÞ is unchanged
by depletion of membrane cholesterol. However, we found
that the average domain size L is increased to be in the range
of ð1:85; 2:48Þmm. In addition, the MbCD-treated group
shows a marked decrease in the confinement strength (and
concomitantly a decrease in a) to bt ¼ 2:950:3. This is
Biophysical Journal 103(8) 1627–1636reflected in the higher slope of MSDðtlag/NÞ displayed
in Fig. 2 C.Cumulative distribution function of squared
step-size
To explore prestin diffusion in greater detail than is possible
with analysis of the MSD, one must have full statistical
knowledge of the step-size distribution. We therefore
measured the probability density of squared step size
pðDr2; tlagÞ and from it measured the cumulative distribution
function (CDF) of squared step size PðDr2; tlagÞ (Eq. 2). The
CDF gives the probability that after time tlag, the particle
will still be found within a squared radius Dr2 from where
it started (31).
We initially reasoned that we should measure the
CDF at the shortest possible time lag of tlag ¼ 250:8ms
because on that timescale the average step size would be
zð4DmicrotlagÞ1=2 ¼ 220nm, which is less than the average
domain size (29) obtained fromMSD analysis for both treat-
ment groups. However, detector averaging has a noticeable
effect on the CDFs at tlag ¼ 250:8ms, where tlag is nearly
equal to the exposure time till ¼ 250 ms (see Supporting
Material and Fig. S4 and Fig. S5 for a detailed discussion
and analysis). We therefore recalculated PðDr2Þ at a longer
tlag of 1:254s for both treatment groups (Fig. 3). At this
longer time lag, detector averaging would only have a 7%
effect on 4Dmicrotlag for free diffusion. Furthermore,
at tlag ¼ 1:254s, the time lag is still below L2=4Dmicro
implied by the average domain size for both groups, and
therefore simple Brownian diffusion is expected (29). For
pure Brownian motion, the expectation is that PðDr2Þ ¼
1 expðDr2=r2oÞ, where r2o is the characteristic diffusive
step. However, we found that fits to a simple Brownian
Cholesterol and Prestin Diffusion 1631model significantly deviated from both untreated and
MbCD CDFs (Fig. 3, dashed curves).
We next explored possible effects that could cause devia-
tions from a pure exponential function predicted for pure
Brownian motion. First, we considered that if there were
a broad distribution of domain sizes L, confined displace-
ments within the smallest domains would appear immobile
(27–30). In particular, displacements within impermeable
domains of an actual size  95nm would appear to
be <22nm, below the position resolution of our system,
and hence indistinguishable from immobile displacements.
We therefore characterized the apparent squared step-size
distribution f ðDr2Þ for immobile prestin-SNAP-TMR in
fixed cells and from it determined the CDF FðDr2Þ ¼R Dr2
0
dDr02f ðDr02Þ (Fig. S3). For a constant positional uncer-
tainty sxy, f ðDr2Þ should be a monoexponential f ðDr2Þ 
eDr
2=4s2xy , which would give FðDr2Þ ¼ 1 eDr2=4s2xy .
However, not surprisingly, the experimentally measured
f ðDr2Þ and FðDr2Þ in Fig. S3 do not fit to a monoexponential
because, as demonstrated in Fig. S1C, there is a distribu-
tion gðsxyÞ of standard deviations with spread ssxy about
the average sxy, which we approximate by gðsxyÞ 
eðsxysxyÞ
2=2s2sxy . This will have the effect of smearing the
exponential distribution in the following fashion:
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To calculate this integral, we simulated fsmearðDr2Þ
numerically (Fig. S2) with the measured parameters ssxy
and sxy, and integrated to obtain FðDr2Þ. The result of
the simulation is in excellent agreement with the
measured CDF (Fig. S3). This demonstrates that in Fig. 3
we have correctly accounted for the apparent motion of
molecules that are either immobile or confined to corrals
that are not resolvable with our spatial and temporal
resolution.
When we fit both control and MbCD groups to Eq. 3, now
with the inclusion of FðDr2Þ (Fig. S3) to account for the
apparent immobility of displacements within small corrals,
we found that the CDF of the untreated group still showed
deviations from a single diffusive component (Eq. 3)
because the CDF rises quicker than the monoexponential
fit (Fig. 3 A, solid curve). This indicates the influence of
barriers to free diffusion in untreated cells that are encoun-
tered during the 1.254s diffusion time window. However, the
diffusive portion of the MbCD-treated group fit perfectly to
a monoexponential (Fig. 3 B, solid curve). The variance of
the fit to the MbCD CDF is more than a factor of 10 lower
than that of the fit to the CDF of the untreated data (Fig. 3).The diffusive portion of the MbCD CDF implies a diffusion
constant of D ¼ 0:06mm2=s and a diffusive fraction of
3¼ 0:685.DISCUSSION
Analysis of MSD reveals that prestin undergoes
slow diffusion in permeable confinements
We first analyzed the MSD of prestin and obtained estimates
of the domain size, confinement strength, and microscopic
diffusion constant for untreated and MbCD-treated groups.
We estimated a relatively small diffusion constant even for
Dmicro compared with the majority of other membrane
proteins examined in studies using SPT, which typically
report diffusion constants on the order of 0.1–1mm2=s
(28,36,37). However, our low estimate for D is consistent
with previous slow estimates obtained with FRAP (20,38).
The slow diffusion of prestin offers an opportunity to
measure the full time course of the MSD describing hop
diffusion, thereby enabling a precise determination of
Dmicro using a modest frame rate. It also enables us to confi-
dently discriminate between confined diffusion and free
diffusion. Our observations directly confirm the hypothesis
of Organ and Raphael (20) that prestin undergoes transiently
confined diffusion in HEK cells.
As a technical note, we cannot fully distinguish confined
diffusion within small corrals from immobility because we
are limited in our spatiotemporal resolution. Thus, we
cannot rule out the occurrence of transient binding of prestin
to other slow or immobile proteins in or near the membrane.
The recent report that prestin binds the microtubule-associ-
ated protein MAP1S (39) provides a possible candidate for
a binding partner in addition to CFTR (40), although it is
unknown whether these proteins are constitutively ex-
pressed in HEK cells. Furthermore, transient binding could
explain the unusually low Dmicro we estimate compared with
other proteins. However, we can rule out the possibility that
we mistook transient binding for confinement, because the
former cannot cause the initial rising phase in MSD
observed in Fig. 2, A and B. In other words, our data indicate
that prestin undergoes confined diffusion and may also
participate in transient binding.Large confinements are modified by cholesterol
MSD analysis reveals confinement of prestin to regions of
an average size ðLT1mmÞ that is large compared with that
obtained in some other studies (28,36,37,41). Even though
L may be overestimated from fitting to the MSD because
of a broad confinement size distribution, the average
confinement area L2 is still a proper estimate according to
Wieser et al. (28). Furthermore, the average size for con-
finements in control cells is close to that reported for
lipid microdomains in other cell types (42,43). ForBiophysical Journal 103(8) 1627–1636
1632 Kamar et al.control cells, the average confinement area is in the range
(1.27, 1.69) mm2, and for cells depleted of membrane
cholesterol, the average confinement area is increased to
be in the interval (3.4, 6.1) mm2. A large confinement size
is also consistent with observations of puncta in prestin-
transfected HEK cells that are clearly resolvable with
confocal microscopy (16,17,20,21). The reversible disap-
pearance of puncta upon depletion of membrane cholesterol
has also been well established (16,17). This is consistent
with our result (Fig. 2) that depletion of membrane
cholesterol reduced the confinement strength from 1152
to 2:950:3, because as bt/1, free diffusion is recov-
ered (28). For confinements that are of equal size and
large enough to observe with conventional microscopy
( 500nm), the residence time of prestin in confinements
within untreated cells would be nearly four times longer
than those in MbCD-treated cells, making confocal fluores-
cence images more diffuse in the latter case.Analysis of CDF demonstrates that cholesterol
depletion removes confinements
MSD analysis only provides the time evolution for the mean
of the distribution of squared displacements. Furthermore, a
broad confinement size distribution would violate the
assumption of a perfectly periodic lattice on which the
hop-diffusion model is based (28). We therefore analyzed
the distribution in its entirety at select time lags to
provide a complementary method that yields more detailed
information.
To reduce the effects of detector averaging, we measured
the CDFs at a time lag of 1.254s (Fig. 3). Minimal effects on
the probability density should be seen at this time lag if the
size of the confinements satisfy L>ð4DmicrotlagÞ1=2z500nm
(28,29,32). Fits to the CDF showed deviations from a single
freely diffusive component for the diffusive fraction of the
untreated group (Fig. 3 A), indicating that confinements
exist in a size range between that which would lead to
apparent immobility (by this we mean confinements small
enough that the fluctuations in squared displacement with
our time resolution would appear less than the localization
offset D) and 500nm. In contrast, the CDF for the MbCD-
treated group fit perfectly with an apparently immobile
component and a single, freely diffusing mobile component
(Fig. 3 B). This observation provides strong evidence that
depletion of membrane cholesterol reduces the number of
barriers to free diffusion, possibly due to removal of choles-
terol-rich microdomains. We can estimate an upper bound
for the size of the putative small confinements that remain
after cholesterol depletion by considering the largest
confinement size for which motion would appear immobile
at a time lag of 1.254s with 250ms averaging time. By
solving MSDhopðtlag ¼ 1:254s;a ¼ 1; L2Þ ¼ D for L, where
D is the localization error offset (see Results in the Support-
ing Material and Fig. S1 B for measurement of D), we calcu-Biophysical Journal 103(8) 1627–1636late an upper bound of 142nm. A more realistic estimate for
a lower bound on the size of the large confinements is given
by L>ð12DmicrotlagÞ1=2 ¼ 867nm (32). In other words, after
cholesterol depletion, we see no evidence of confinements
between 142 and 867nm.Possible origins of confinement
Our results demonstrate that membrane cholesterol is a
major source of confinement for prestin in the HEK cell.
Previous biochemical studies showed a decrease of prestin
in the raft fraction containing flotillin-1 and integrin2a/
VLA-2a, which are known membrane microdomain
markers, and a relative increase in heavier membrane frac-
tions for depletion of cholesterol using sucrose density
gradient fractionation (16,17). However, a decrease in the
microdomain markers was also observed, indicating that
the reduction of prestin in the raft fraction may be a result
of raft removal and concomitant removal of prestin. Further-
more, prestin diffusion measured using FRAP showed no
increase in prestin mobile fraction for cholesterol depletion
(38). In addition, Sfondouris et al. (18) reported that
cholesterol depletion in transfected HEK cells did not
increase prestin-associated charge movement (which the
authors attributed to endocytosis of prestin caused by
MbCD) even though loading cholesterol reduced charge
movement. Together with our observation that some
confinements remain upon cholesterol depletion, these
previously obtained results tend to argue against a simple
redistribution of prestin out of domains that do not change
in size. Instead, we envisage that a fraction of prestin
molecules undergo confined diffusion in cholesterol-rich
microdomains and another portion is confined in the
lower-cholesterol regions between the microdomains. The
microdomains are probably superimposed on a heteroge-
neous membrane environment including a cytoskeletal
meshwork. In this scenario, depletion of cholesterol makes
the microdomains smaller and/or reduces their number.
Both scenarios would increase the area between microdo-
mains and increase the relative amounts of prestin in
the low-cholesterol regions (which are now effectively
larger confinements), explaining the larger average L2 for
the MbCD-treated group extracted from MSD analysis
(Fig. 2), and our observation of an apparent removal of
barriers to diffusion (Fig. 3).
It is interesting that cholesterol depletion preserves a
significant portion of small confinements, suggesting that
many of them (i.e., those <142 nm) may not be part of
the detergent-resistant membrane fraction and instead may
be confinements due to the cytoskeleton. It is worth noting
that cytoskeletal confinements to DOPE (a phospholipid
probe) 68nm in size have been found in HEK293 cells at
25ms resolution (44), and could be the identity of the small
confinements that remained after cholesterol depletion in
our study. Although we have not performed cytoskeletal
Cholesterol and Prestin Diffusion 1633treatments, it is possible that the domains are contained
within or bound to cytoskeletal fences, or that prestin has
a direct interaction with the cytoskeleton, conforming to
the anchored-protein picket model and/or the membrane-
skeleton fence model (37,45,46). Prestin has a large cyto-
plasmic domain, STAS (47), and it is not unreasonable to
assume that part of the confinement to prestin after choles-
terol depletion involves corralling of STAS with the cyto-
skeleton. Of interest, these models generally propose that
the membrane protein confinement size should usually be
unaffected by membrane cholesterol (46). The observation
that prestin confinement size is clearly dependent on choles-
terol is still consistent with the anchored-protein picket
model because the density of pickets could be cholesterol
dependent. Alternatively, MbCD could have secondary
effects on the cytoskeleton. MbCD may directly affect the
cytoskeleton or indirectly affect proteins that contribute to
the organization of the cytoskeleton (48,49). Indeed,
multiple studies have reported cholesterol-dependent
membrane confinements coexisting with cholesterol-inde-
pendent confinements (50–52), and our results suggest that
this is likely the case with prestin.Cholesterol depletion does not modify
microscopic diffusion constant
Of interest, we found that cholesterol depletion did not
change the microscopic diffusion constant of prestin in
HEK cells. This is in agreement with FRAP results (38)
that also showed no change in the effective diffusion
constant with cholesterol depletion. Lipid diffusion in
HEK cells also shows no change in D upon depletion of
membrane cholesterol (53). This is in contrast to OHCs in
which lipid lateral mobility is dependent on cholesterol
and seems to be tuned to maximize lipid fluidity at native
cholesterol concentration (53). These results partially
support the hypothesis that alterations in prestin function
observed after cholesterol loading of HEKs (Vpkc shift and
charge density reduction) result from decreases in mem-
brane fluidity that restrict the conformational flexibility of
prestin (18). However, this interpretation is inconsistent
with the observation that lipid mobility is actually decreased
for cholesterol depletion in OHCs (53), because that should
cause a hyperpolarizing shift in Vpkc, whereas a depolarizing
shift is actually observed (16). Furthermore, lipid mobility
in HEK cells is insensitive to cholesterol depletion (53)
while Vpkc shifts remain (16–18). Thus, our results taken
together with previous findings imply that cholesterol deple-
tion affects prestin function by a mechanism other than
changes in overall membrane fluidity.Cholesterol and prestin function
It was previously suggested that cholesterol may affect
prestin function by modifying the overall mechanicalproperties of the membrane (e.g., stiffness, compressibility,
and thickness), either directly or by changing cytoskeleton
membrane association (16,18,54). However, our results
raise the possibility that prestin sensitivity to cholesterol
is related to participation with ordered domains that depend
on cholesterol such as lipid rafts. These two concepts are
not mutually exclusive. Prestin residing within lipid
rafts may function differently from prestin outside the
domains, due to a direct interaction either with cholesterol
or with the local environment. Therefore, cholesterol
depletion may tune NLC by removing a functionally distinct
prestin population from membrane microdomains and
increasing the contribution of prestin outside the micro-
domains to whole-cell properties. Prestin molecules within
the DRM fraction could have altered function because 1),
lipid rafts increase or force prestin-prestin interactions
that affect function; 2), prestin molecules within lipid
rafts are brought near other raft-associated molecules
(such as cholesterol or other raft-associated proteins) that
affect function; or 3), prestin molecules in the lipid
rafts have reduced conformational flexibility that affects
Vpkc. Scenario 1 is supported by studies that demonstrated
that prestin oligomerization can effect NLC (55), and
that changes in membrane cholesterol may affect prestin
oligomerization (16). The fact that prestin colocalizes with
integrin molecules (16,17) and caveolin (21) indirectly
supports scenarios 2 and 3, because both are often found
as components of large protein-lipid clusters that are
likely to have decreased fluidity and increased molecular
crowding (56,57), which could affect the conformational
flexibility of prestin.Relevance to prestin function in OHCs
Thus far, we have discussed how our observations relate to
membrane organization and prestin-associated charge
movement (NLC) in HEKs. However, prestin in the
OHC generates a robust electromechanical motion, and
the interaction of prestin with the OHC cytoskeleton is an
important research area (58,59). The cytoskeleton of the
OHC consists of a cortical lattice comprising oriented
domains of actin filaments that are bridged to the plasma
membrane by pillar structures of unknown origin (60–63).
There is evidence for structural (64) and functional (65)
domains in the OHC, and the cytoskeletal structure of the
OHC could define domains in the OHC plasma membrane.
OHCs in prestin-null mice lack this organized cytoskeletal
structure, suggesting that prestin is required to maintain it
(66). Recently, it was shown that actin depolymerization
mediated by LIM-kinases/Rho-GTPases regulates electro-
motility (67,68). This type of cytoskeletal reorganization
would likely result in changes to prestin diffusion and
confinement. Although the detailed nature of prestin-
cytoskeletal interactions in HEK cells and OHCs is not fully
understood, it is reasonable to expect that conservedBiophysical Journal 103(8) 1627–1636
1634 Kamar et al.physiological mechanisms are present, because there is
a dynamic interdependence between cytoskeletal and
membrane organization in all cell types. Furthermore,
prestin charge movement has the same sensitivity to choles-
terol manipulations when it is expressed in OHCs or HEK
cells, suggesting that prestin sensitivity to cholesterol is
likely not critically dependent on the unique structure of
OHCs. Thus, a characterization of prestin diffusion and
confinement in the HEK cell provides an important model
system for understanding prestin organization and function
in the OHC.CONCLUSIONS
In this study, we characterized prestin diffusion in the HEK
cell using SPT. A comparison of the full time course of
MSD with a hop-diffusion model demonstrates that prestin
undergoes confined diffusion in a broad size range of con-
finements. Depletion of membrane cholesterol increases
the average confinement size and reduces the confinement
strength, consistent with the observation that cholesterol
depletion reversibly abolishes punctate fluorescence of
prestin-transfected cells. These results support the view
that a portion of prestin localizes to cholesterol-rich
microdomains and that membrane cholesterol is a major
source of prestin confinement. An analysis of the statistical
distribution of squared displacements (CDF analysis)
supports the results of fitting MSD to a hop-diffusion
model. Depletion of membrane cholesterol removes
barriers to free diffusion, resulting in a greater average
confinement size. We hypothesize that cholesterol affects
prestin function by modifying its interactions with mem-
brane substructures. Although more research is needed
to determine whether the ability of cholesterol to modulate
prestin function results from effects related to prestin
organization or to overall modifications of passive
membrane mechanical properties, our observations add
support to the growing view that the microscale organiza-
tion of prestin in the plasma membrane influences prestin
function.SUPPORTING MATERIAL
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